Raltegravir with optimized background therapy for resistant HIV-1 infection, N Engl J Med, vol.359, issue.4, pp.339-354, 2008. ,
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/ emtricitabine in treatment-naive HIV-1-infected patients, J Acquir Immune Defic Syndr, vol.63, issue.1, pp.77-85, 2013. ,
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrugresistant HIV-1-infected patients: a randomized open-label trial, HIV Clin Trials, vol.11, issue.5, pp.283-293, 2010. ,
A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease, AIDS, vol.12, issue.12, pp.1495-1502, 199820. ,
Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa, BMC Public Health, vol.14, p.676, 2014. ,
Quality of life in asymptomatic-and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group, AIDS, vol.14, issue.2, pp.181-187, 2000. ,
Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era, AIDS, vol.24, issue.10, pp.1387-1405, 2010. ,
Assessment and treatment of HIV-related fatigue, J Assoc Nurses AIDS Care, vol.12, pp.29-34, 2001. ,
DOI : 10.1177/105532901773742266
Intensity, chronicity, circumstances, and consequences of HIV-related fatigue: a longitudinal study, Clin Nurs Res, vol.23, issue.5, pp.514-528, 2014. ,
Fatigue in HIV and AIDS: an analysis of evidence, J Assoc Nurses AIDS Care, vol.24, issue.1, pp.5-14, 2013. ,
Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, J Viral Hepat, vol.17, issue.9, pp.650-660, 2006. ,
Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research, HIV Clin Trials, vol.8, issue.5, pp.320-327, 2007. ,
Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8) Qual Life Res, vol.16, pp.577-591, 2007. ,
Effect of lopinavir/ ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial, Antivir Ther, vol.13, issue.4, pp.591-599, 2008. ,
Real life evaluation of HIV-1 infected patients treated with an ARV combination therapy including raltegravir in France the final RACING study results (M24) 14th European AIDS Conference, 2013. ,
Development and validation of a self-completed HIV symptom index, J Clin Epidemiol, vol.54, issue.12, pp.77-90, 2001. ,
Measuring the functional impact of fatigue: initial validation of the fatigue impact scale, Clin Infect Dis, vol.18, issue.1, pp.79-83, 1994. ,
Chronicity and remission of fatigue in patients with established HIV infection, AIDS Patient Care STDs, vol.23, issue.4, pp.239-244, 2009. ,
Patient-Reported symptoms on the antiretroviral regimen efavirenz/ emtricitabine/tenofovir, AIDS Patient Care STDs, vol.26, issue.6, pp.312-319, 2012. ,
DOI : 10.1089/apc.2012.0044
URL : http://europepmc.org/articles/pmc3412583?pdf=render
Quality of life in HIV-1 patients treated with raltegravir ,
URL : https://hal.archives-ouvertes.fr/inserm-01986117
Predictors and correlates of fatigue in HIV/AIDS, J Pain Symptom Manage, vol.29, issue.2, pp.173-184, 2005. ,
Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study, AIDS, vol.21, issue.1, pp.19-27, 2007. ,
Housing characteristics and their influence on health-related quality of life in persons living with HIV in Ontario, Canada: results from the positive spaces, healthy places study, AIDS Behav, vol.16, issue.8, pp.2361-2373, 2012. ,
Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: a cross-sectional analytical study, BMC Public Health, vol.7, p.682, 2007. ,
An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment, Med Sci Monit, vol.12, issue.12, pp.493-500, 2006. ,
Lipodystrophy and quality of life of HIV-infected persons, AIDS Rev, vol.10, issue.3, pp.152-161, 2008. ,
Factors associated with fatigue in acquired immunodeficiency syndrome patients with antiretroviral drug adverse reactions: a retrospective study, J Tradit Chin Med, vol.33, issue.3, pp.316-321, 2013. ,
DOI : 10.1016/s0254-6272(13)60172-7
URL : https://doi.org/10.1016/s0254-6272(13)60172-7
Self-reported medication adherence and symptom experience in adults With HIV, J Assoc Nurses AIDS Care, vol.22, issue.4, pp.257-268, 2011. ,
DOI : 10.1016/j.jana.2010.11.004
URL : http://europepmc.org/articles/pmc3117946?pdf=render
Morbidity and mortality in HIV-infected individuals-a shift towards comorbidities, Swiss Med Wkly, vol.139, pp.564-570, 2009. ,
Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8), Qual Life Res, vol.16, issue.4, pp.577-591, 2007. ,